本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Tyra Biosciences, Inc.

10.39
-0.4700-4.33%
盤後10.810.4200+4.04%17:24 EDT
成交量:10.42萬
成交額:110.40萬
市值:5.53億
市盈率:-6.36
高:11.19
開:11.00
低:10.38
收:10.86
資料載入中...
2024/11/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/19

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/10/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/28

重要事件披露

Form 8-K - Current report
2024/10/25

重要事件披露

Form 8-K - Current report
2024/10/22

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/22

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/18

重要事件披露

Form 8-K - Current report
2024/10/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/15

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/15

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities